---
created: 2025-04-13
updated: 2025-04-13T10:53
id: m%eL;Kz=CC
specialty: pharmaco
specialty_id: 330
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::04-cancer-drugs::02-alkylating-agents
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::13-alkylating-agents
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::13-alkylating-agents::ifosfamide
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/pixorize::02-biochem::22-onc-drugs::07-cyclophosphamide,-ifosfamide
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::02-dna-&-cellular-division::01-cyclophosphamide,-ifosfamide,-busulfan,-nitrosoureas-(carmustine,-lomustine,-streptozocin)::zanki-extra
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::7000-7999::7626
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
Ifosfamide can cause a generalized reabsorptive defect of bicarbonate in the **PCT proximal convoluted tubule** = Type 2 RTA Fanconi syndrome

---

# Answer
